AOA 2025: Lifitegrast 5.0% shows positive effect on clinical signs and biomarkers in patients with dry eye disease

Published on June 26, 2025
Lifitegrast 5.0% significantly improves clinical signs and biomarkers in dry eye disease, demonstrating effective results within 12 weeks of treatment.
Continue reading on website
Other news

AOA 2025: Should you be concerned about pediatric dry eye during myopia management?

June 26, 2025
Optometrists learn to recognize and manage pediatric dry eye and myopia, emphasizing proactive care and lifestyle changes for better outcomes.

Innovation Hub sparks thoughtful conversations about AI, technology in eye care

June 26, 2025
Optometry Times delivers clinical news, practice insights, and research updates by optometrists for optometrists to advance care and patient outcomes.